839-P: Efficacy and Safety of HDG1901 vs. Ozempic in Patients with Type 2 Diabetes (T2D)—A Randomized, Open-Label, Bioequivalence Phase 3 TrialLixin Guo, Junying Xu, Zhifeng Cheng et al.|Diabetes|2025Cited by 0